Critical Care
Our hospital portfolio focuses on the following therapeutic areas: infectious diseases, epilepsy and haemorrhage.
We rethink
generics
Towards More Efficient Healthcare
Our portfolio consists of over 15 products covering hospital-used medications, oral contraceptives, and medical devices. Stragen specializes in the development and distribution of hormonal products, niche modified-release medications, and conventional solid release forms. We also develop and distribute high-quality parenteral medications, such as antibiotics.
Women Health
Our products for women's health includes a whole range of oral contraceptives as well as a product for treatment of endometriosis.
Consumer Health
Our products are CE-marked medical devices which consist of carefully selected active ingredients based on scientific evidence. Our consumer health products offer solutions for intimate health.
R&D
Our specialized and dedicated scientific team works continuously according to the latest quality standards to provide tailored solutions to our partners. Committed to patient well-being and treatment adherence, Stragen Laboratory initiates research projects focused on fundamental criteria, namely:
- Innovation through new formulations to enhance the tolerance of our products.
- Development of new stability data to improve the use of our products.
- Introduction of new dosage forms to facilitate the use of our products, especially in emergency situations.
- Launch of new packaging and dosages to diversify our propositions and satisfy the needs and expectations of our partners more proficiently.